INGRAM DOUGLAS S
Insider CIK 1190644 · NMUS Vice Chairman, Director · ENDP Director · RLAY Director · AGN President · SRPT President & CEO, Director · ARWR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 32,947 | — | $0 | 32,947 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 46,215 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2025-12-07 | 2025-12-09 | 96,541 | — | $0 | 659,849 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2025-12-07 | 2025-12-09 | 269,542 | — | $0 | 929,391 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2025-12-07 | 2025-12-09 | 50,000 | — | $0 | 440,307 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2025-12-07 | 2025-12-09 | 50,000 | — | $0 | 490,307 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2025-12-07 | 2025-12-09 | 73,001 | — | $0 | 563,308 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-06 | 136,681 | — | $0 | 136,681 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-02-06 | 2025-02-07 | 38,396 | $20.09 | $771.4K | 38,396 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2024-06-03 | 2024-06-05 | 102,225 | — | $0 | 102,225 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 3,884 | $80.33 | $312.0K | 390,107 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 10,081 | $78.57 | $792.1K | 375,163 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 11,060 | $79.70 | $881.5K | 386,223 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 200 | $81.26 | $16.3K | 390,307 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2023-05-31 | 2023-06-01 | 66,055 | — | $0 | 66,055 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2022-05-27 | 2022-05-27 | 41,597 | — | $0 | 41,597 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2021-11-17 | 2021-11-17 | 25,026 | $79.94 | $2.00M | 365,082 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2021-06-26 | 2021-06-28 | 17,812 | $80.40 | $1.43M | 340,056 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2021-05-19 | 2021-05-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2020-12-31 | 2021-01-04 | 37,144 | $170.49 | $6.33M | 357,868 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | P Buy | 2020-07-20 | 2020-07-21 | 25,000 | $20.00 | $500.0K | 25,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2019-12-31 | 2020-01-03 | 37,185 | $129.04 | $4.80M | 395,012 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2019-08-12 | 2019-08-12 | 8,460 | $122.76 | $1.04M | 424,405 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2019-08-12 | 2019-08-12 | 7,792 | $123.41 | $961.6K | 432,197 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2018-10-30 | 2018-10-30 | 3,134 | $120.94 | $379.0K | 415,945 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2018-10-30 | 2018-10-30 | 13,561 | $120.26 | $1.63M | 412,811 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2018-08-15 | 2018-08-16 | 16,000 | $125.26 | $2.00M | 399,250 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-06-26 | 2018-06-27 | 36,946 | $135.53 | $5.01M | 383,250 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2017-11-08 | 2017-11-13 | 38,138 | $52.44 | $2.00M | 420,196 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | P Buy | 2017-07-27 | 2017-07-28 | 47,058 | $42.50 | $2.00M | 382,058 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-06-26 | 2017-06-28 | 3,300,000 | — | $0 | 3,300,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2017-06-26 | 2017-06-28 | 335,000 | — | $0 | 335,000 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2017-06-09 | 2017-06-12 | 11,488 | $11.49 | $132.0K | 17,336 | SEC↗ |
| ENDP Endo International plc | A Award | 2017-06-09 | 2017-06-12 | 23,934 | — | $0 | 28,824 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-05-05 | 2016-05-09 | 9,403 | $26.59 | $250.0K | 9,403 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-05-05 | 2016-05-18 | 9,403 | $26.59 | $250.0K | 9,403 | SEC↗ |
| ENDP Endo International plc | S Sale | 2016-05-05 | 2016-05-18 | 4,513 | $26.59 | $120.0K | 4,890 | SEC↗ |
| NMUS Nemus Bioscience, Inc. | A Award | 2015-10-20 | 2015-10-22 | 60,000 | — | $0 | 372,500 | SEC↗ |
| NMUS Nemus Bioscience, Inc. | C Conversion deriv | 2015-08-20 | 2015-08-24 | 100,000 | — | $0 | 0 | SEC↗ |
| NMUS Nemus Bioscience, Inc. | C Conversion | 2015-08-20 | 2015-08-24 | 312,500 | — | $0 | 312,500 | SEC↗ |
| NMUS Nemus Bioscience, Inc. | A Award deriv | 2015-06-01 | 2015-06-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 105,500 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 70,431 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 419 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 60,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 67,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 82,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 92,600 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 130,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 89,200 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 3,617 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2015-03-17 | 2015-03-19 | 16,911 | — | $0 | 16,911 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 16,911 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 2,677 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 10,772 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 60,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 67,000 | — | $0 | 67,000 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 67,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 92,600 | — | $0 | 92,600 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 92,600 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 130,400 | — | $0 | 130,400 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 130,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 89,200 | — | $0 | 89,200 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 89,200 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 82,000 | — | $0 | 82,000 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 82,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 105,500 | — | $0 | 105,500 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 105,500 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2015-03-10 | 2015-03-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2015-02-25 | 2015-03-19 | 13,044 | — | $0 | 10,772 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2015-02-20 | 2015-02-24 | 419 | — | $0 | 419 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2014-02-21 | 2014-02-25 | 70,431 | $125.07 | $8.81M | 70,431 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-02-21 | 2014-02-25 | 1 | $125.70 | $96 | 1,044 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2014-02-14 | 2014-02-19 | 84,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2014-02-14 | 2014-02-19 | 84,000 | $55.98 | $4.70M | 85,058 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-02-14 | 2014-02-19 | 84,000 | $124.40 | $10.45M | 1,058 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2014-02-14 | 2014-02-19 | 13 | $124.57 | $1.6K | 1,045 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2013-02-21 | 2013-02-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2013-02-15 | 2013-02-20 | 357 | $108.02 | $38.6K | 23,829 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-08-30 | 2012-08-31 | 100,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-08-30 | 2012-08-31 | 100,000 | $85.78 | $8.58M | 24,183 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-08-30 | 2012-08-31 | 100,000 | $36.15 | $3.62M | 124,183 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-02-22 | 2012-02-24 | 148 | $87.27 | $12.9K | 24,183 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-02-17 | 2012-02-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-02-17 | 2012-02-22 | 517 | — | $0 | 24,331 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-02-07 | 2012-02-08 | 66,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-02-07 | 2012-02-08 | 66,000 | $41.24 | $2.72M | 89,814 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-02-07 | 2012-02-08 | 66,000 | $86.37 | $5.70M | 23,814 | SEC↗ |